Publications by authors named "E I Ermakov"

Patients with systemic lupus erythematosus (SLE) are known to frequently suffer from comorbid cardiovascular diseases (CVDs). There are abundant data on cytokine levels and their role in the pathogenesis of SLE, while growth factors have received much less attention. The aim of this study was to analyze growth factor levels in SLE patients and their association with the presence of comorbid CVDs.

View Article and Find Full Text PDF
Article Synopsis
  • Delirium Tremens (DT) is a severe complication of alcohol withdrawal syndrome (AWS), linked to neurotransmitter issues, inflammation, and increased bodily permeability, but its biomarkers are not well understood.
  • The study compared healthy individuals and two AWS patient groups (with and without DT) to analyze various biomarkers, finding significant changes in certain biochemical markers and elevated inflammatory indicators in DT patients.
  • Results suggested a subgroup of AWS patients exhibited high inflammation, indicating the complexity of patient profiles in AWS and highlighting the need for further research into specific biomarkers related to DT.
View Article and Find Full Text PDF

Anti-DNA antibodies are known to be classical serological hallmarks of systemic lupus erythematosus (SLE). In addition to high-affinity antibodies, the autoantibody pool also contains natural catalytic anti-DNA antibodies that recognize and hydrolyze DNA. However, the specificity of such antibodies is uncertain.

View Article and Find Full Text PDF

Immune gene variants are known to be associated with the risk of psychiatric disorders, their clinical manifestations, and their response to therapy. This narrative review summarizes the current literature over the past decade on the association of polymorphic variants of cytokine genes with risk, severity, and response to treatment for severe mental disorders such as bipolar disorder, depression, and schizophrenia. A search of literature in databases was carried out using keywords related to depressive disorder, bipolar disorder, schizophrenia, inflammation, and cytokines.

View Article and Find Full Text PDF

Machine learning and artificial intelligence technologies are known to be a convenient tool for analyzing multi-domain data in precision psychiatry. In the case of schizophrenia, the most commonly used data sources for such purposes are neuroimaging, voice and language patterns, and mobile phone data. Data on peripheral markers can also be useful for building predictive models.

View Article and Find Full Text PDF